300 PLZID (Zidovudine 300 mg)
Pill with imprint 300 PLZID is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Teva Pharmaceuticals USA.
Zidovudine is used in the treatment of hiv infection; occupational exposure; reduction of perinatal transmission of hiv; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 300 PLZID
Zidovudine
- Imprint
- 300 PLZID
- Strength
- 300 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (nrtis)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- National Drug Code (NDC)
- 00093-5530 (Discontinued)
More about zidovudine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
- Drug Information
- Zidovudine (Advanced Reading)
- Zidovudine Intravenous (Advanced Reading)
- Zidovudine Capsules and Tablets
- Zidovudine Injection
- Zidovudine Syrup
- Other brands
- Retrovir
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.